INTERCEPT PHARMACEUTICALS IN

CUSIP: 45845P108 Class: Common Stock

Gladius Capital Management LP's Holding History (CIK: 0001540656)

Note: Option positions (PUT/CALL) are excluded.

Q1 2023
Shares 1,899 Value ($000) $26 Avg Close — Range —
Q4 2022
Shares 2,565 Value ($000) $32 Avg Close — Range —